NCT03528837 is a clinical trial in Neonatal Acute Kidney Injury, sponsored by Assiut University.

Who is sponsoring NCT03528837?

NCT03528837 is sponsored by Assiut University.

What condition does NCT03528837 study?

NCT03528837 studies Neonatal Acute Kidney Injury.

Is NCT03528837 still recruiting?

NCT03528837 is currently status unknown. Last updated 18 May 2018.

Last reviewed 2018-05-18 · How we verify

NCT03528837

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Kidney Injury in Neonates at NICU in Assiut University Children Hospital Descriptive Study

Status unknown Last updated 18 May 2018

What this trial tests

trial in Neonatal Acute Kidney Injury in 30 participants. Status unknown.

Timeline

30 June 2018

Primary endpoint
1 July 2019

1 August 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	30 June 2018
Primary completion	1 July 2019
Estimated completion	1 August 2019
Sites	1 location across Egypt

Conditions studied

Neonatal Acute Kidney Injury — all drugs for Neonatal Acute Kidney Injury →

Sponsor

Assiut University

Who can join

Adults 1 Day to 28 Days, any sex, with Neonatal Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury (AKI) is a complex disorder with clinical manifestations ranging from mild dysfunction to complete anuric kidney failure. Its leads to sudden and rapid decline in renal excretory function within hours to days,accompanied by accumulation of nitrogenous waste products such creatinine,urea and other clinically un measured products

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03528837 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 18 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03528837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing